A Pilot Study to Evaluate the Safety and Efficacy of the Long-acting IL-1 Inhibitor, Rilonacept (IL-1 Trap) in Patients with Familial Cold Autoinflammatory Syndrome (FCAS)

OBJECTIVE: Familial cold autoinflammatory syndrome (FCAS) is caused by mutations in CIAS1 leading to excessive secretion of IL-1β, which is associated with cold induced fevers, joint pain and systemic inflammation. This pilot study was conducted to assess the safety and efficacy of the long acting I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Goldbach-Mansky, Raphaela, Shroff, Sharukh, Wilson, Mildred, Snyder, Christopher, Plehn, Sara, Barham, Beverly, Pham, Tuyet Hang, Kastner, Daniel L., Pucino, Frank, Wesley, Robert A., Papadopoulos, Joanne, Weinstein, Steven, Mellis, Scott
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875198/
https://ncbi.nlm.nih.gov/pubmed/18668591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.23620
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars